Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

NCT00821444 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ziprasidone
DRUG: B16 Fasted
DRUG: B16 Fed

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.